63 studies found for:    Open Studies | "Hair Diseases"
Show Display Options
Rank Status Study
21 Recruiting A Study With INCB018424 Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)
Condition: Alopecia Areata
Interventions: Drug: Placebo Cream;   Drug: INCB018424 Phosphate Cream
22 Recruiting PAI-1 Expression in Non-scarring Hair Loss
Conditions: Androgenetic Alopecia;   Telogen Effluvium;   Alopecia Areata
Intervention:
23 Not yet recruiting A Prospective Multi-Center Study of a Novel Dual-Wavelength Laser for Hair Removal
Condition: Hypertrichosis
Intervention: Device: 755nm and 1064nm Nd:YAG laser
24 Recruiting Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer
Condition: Non-Metastatic Breast Cancer
Interventions: Other: Clinical Assessments;   Behavioral: Questionnaires;   Other: Saliva sample
25 Recruiting Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
Condition: Androgenetic Alopecia
Interventions: Device: LH80 PRO;   Device: Sham Device
26 Recruiting Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan
Condition: Eyelash Hypotrichosis
Intervention: Drug: Bimatoprost cutaneous solution 0.03%
27 Recruiting STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia
Condition: Alopecia, Androgenetic
Interventions: Device: Puregraft System;   Device: Celution System;   Procedure: Kerastem Therapy;   Procedure: Liposuction
28 Recruiting Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries
Conditions: Hirsutism;   Dermatitis;   Seborrheic Alopecia;   Severe Acne;   Seborrhea
Intervention:
29 Not yet recruiting Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
Conditions: Female Pattern Hair Loss;   Androgenetic Alopecia
Interventions: Drug: 5% Topical Minoxidil Solution;   Drug: 15% Topical Minoxidil Solution
30 Not yet recruiting The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
Condition: Female Androgenetic Alopecia
Interventions: Drug: 5% Minoxidil;   Drug: 200mg Spironolactone;   Drug: 5mg Finasteride;   Other: Placebo
31 Not yet recruiting Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia
Condition: Frontal Fibrosing Alopecia
Intervention: Other: Corticosteroid/Saline
32 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Conditions: Post Radiation/Chemotherapy Alopecia Presents With Hair Thinning.;   Post-burn Alopecia Presents With Hair Thinning.;   Cicatricial Alopecia Presents With Hair Thinning.;   Androgenetic Alopecia Presents With Hair Thinning;   Alopecia Due to Traumatic Injuries Presents With Hair Thinning.;   Alopecia Due to Skin Disease Presents With Hair Thinning.
Intervention: Device: Anchoring system
33 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
34 Recruiting Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Biological: PRP
35 Recruiting The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
Condition: ALOPECIA AREATA
Interventions: Drug: Methotrexate;   Drug: Placebo
36 Recruiting Scalp Cooling to Prevent Chemo-induced Hair Loss
Conditions: Breast Cancer;   Alopecia
Interventions: Device: PAXMAN Orbis Scalp Cooler;   Other: Control No treatment
37 Recruiting Pilot Study of the Effect of Laser on Reversing Chronic Radiation Injury
Condition: Chronic Radiation Dermatitis
Interventions: Device: Fractional CO2 laser treatment;   Other: No treatment
38 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Intralesional Triamcinolone 2.5 mg/ml;   Drug: Intralesional Triamcinolone 5 mg/ml;   Drug: Intralesional Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
39 Unknown  Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
40 Unknown  Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Interleukin-2

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years